Description of Medical Areas
About the FDA Approved Listings
|
 |
Drugs Approved by the FDA (2006)
|
The following drugs have been approved this year by
the Food and Drug Administration.
Cardiology/Vascular Diseases
|
|
Ranexa (ranolazine); For the treatment of chronic angina in patients failing first-line therapy; CV Therapeutics; Approved January 2006
Dental/Maxillofacial Surgery
|
|
Dermatology/Plastic Surgery
|
|
Verdeso (desonide); For the treatment of atopic dermatitis; Connetics; Approved September 2006
Elestrin (estradiol gel); For the treatment of vasomotor symptoms associated with menopause; BioSante; Approved December 2006
Amitiza (lubiprostone); For the treatment of chronic idiopathic constipation; Sucampo/Takeda; Approved January 2006
Dacogen (decitabine); For the treatment of both treatment-naïve and -experienced Myelodysplastic Syndromes; MGI Pharma; Approved May 2006
Immunology/Infectious Diseases
|
|
Prezista (darunavir); For the treatment of treatment-resistant HIV infections; Tibotec; Approved June 2006
Elestrin (estradiol gel); For the treatment of vasomotor symptoms associated with menopause; BioSante; Approved December 2006
Sprycel (dasatinib); For the treatment of imatinib-resistant chronic myeloid leukemia; Bristol-Myers Squibb; Approved June 2006 Sutent (sunitinib); For the treatment of kidney cancer and gastrointestinal stromal tumors; Pfizer; Approved January 2006
Lucentis (ranibizumab); For the treatment of neovascular (wet) age related macular degeneration; Genentech; Approved June 2006
Elaprase (idursulfase); For the treatmenr of mucopolysaccharidosis II (Hunter Syndrome); Shire Pharmaceuticals; Approved July 2006
Pulmonary/Respiratory Diseases
|
|
Elaprase (idursulfase); For the treatmenr of mucopolysaccharidosis II (Hunter Syndrome); Shire Pharmaceuticals; Approved July 2006
Trauma/Emergency Medicine
|
|
|
|
Back to Centerwatch Drug Directories
|
